The NStaging System in Nasopharyngeal Carcinomawith Radiation Therapy Oncology Group Guidelines for Lymph Node Levels Based onMagnetic Resonance Imaging

Yan-PingMao,Shao-Bo Liang,Li-Zhi Liu,Yong Chen,Ying Sun,Ling-Long Tang,Li Tian,Ai-Hua Lin,Meng-Zhong Liu,Li Li

2008-01-01

Abstract:Purpose:To evaluate the prognostic value of variables including nodal size, level, laterality, extranodal neoplastic spread (ENS), and necrosis in patients with nasopharyngeal carcinoma (NPC) and further explore the feasibility of an N-staging system using RadiationTherapy Oncology Group (RTOG) guidelines for lymph node levels based on magnetic resonance imaging (MRI). Experimental Design: The MRI scans of 924 patients with histologically diagnosed nondisseminated NPC were reviewed retrospectively.The distribution of the tumors was mapped using RTOG guidelines and laterality. The multiplicity of each tumor was calculated, as well as the size and status of ENS and the necrosis of individual nodes. Results: Nodal level, cervical lymph node laterality, and ENS were independent prognostic factors for disease failure and distant failure in multivariate analyses. There was no significant difference in the hazard ratios (HR) for distant failure between level II and retropharyngeal, level Ib, levelV, or level III involvement, whereas patients with level IVand supraclavicular fossa involvement had a significant increase in HRs.The subsets that made up a given N stage group had similar HRs for distant failure. Both the HRs for disease failure and distant failure by the proposed N staging system between one stage and the next were statistically significant (P < 0.05). The survival curves of disease-free survival and distant metastasis-free survival for all subclassifications of N stage showed significant difference from the adjacent stage (P < 0.05). The overall distribution pattern of the proposed N staging was more equitable than that of the 6th American Joint Committee on Cancer N staging. Conclusions: Nodal variables including level, cervical lymph node laterality, and ENS are independent prognostic factors for NPC. The proposed N staging system of NPC using RTOG guidelines basedon MRI is highly predictive and may provide a more objective method for staging NPCs. Nasopharyngeal carcinoma (NPC) occurs with much greater frequency in southern China, northern Africa, and Alaska (1), and the incidence remains high among Chinese people who have immigrated to southeast Asia or North America (2). The reported yearly incidence rate is 30 to 80 per 100,000 in southern China (3). The tumor-node-metastasis staging system is crucial for predicting prognosis, guiding treatment strategy for different risk groups, and facilitating exchange of experience between oncology centers (4). However, a variety of N staging systems for NPC have been used in the past. The two most widely used systems, Ho’s system and the International Union Against Cancer/American Joint Committee on Cancer (AJCC) system, each have their own merits in predicting outcome and guiding treatment (5). The 5th edition of the AJCC system for NPC, which merged the two, has been reported to be superior over the previous systems in terms of improved prognostication and a more balanced distribution between stages (6, 7). No further changes have been introduced into the current 6th edition of the AJCC N staging system (4). However, N staging by the 6th edition of the AJCC system for NPC does have limitations. First, the N staging criteria mainly depend on clinical examination, which is by no means perfect (8). For example, palpation-determined nodal size differs among clinicians. In addition, the definition of the supraclavicular fossa (SCF), originally described by Ho, is based primarily on clinical landmarks, and there is no reliable way to Imaging, Diagnosis, Prognosis Authors’Affiliations: State Key Laboratory of Oncology in Southern China; Imaging Diagnosis and Interventional Center, Cancer Center, Department of Radiation Oncology, Cancer Center, and Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, People’s Republic of China Received 2/1/08; revised 4/14/08; accepted 5/1/08. Grant support: National Natural Science Foundation of China (No.30470505), Science Foundation from Sci-Tech Office of Guangdong Province, China (No.2004B5050301005), and Science Foundation of Key Hospital Clinical Programme from Ministry of Health, People’s Republic of China (No.2007-353). The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked advertisement in accordance with18 U.S.C. Section1734 solely to indicate this fact. Note:Y-P. Mao and S-B. Liang contributed equally to this work. Requests for reprints: Jun Ma, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, 651Dongfeng Road East, Guangzhou 510060, People’s Republic of China. Phone: 86-20-87343469; Fax: 86-20-87343295; E-mail: majun2@mail.sysu.edu.cn. F2008 American Association for Cancer Research. doi:10.1158/1078-0432.CCR-08-0271 www.aacrjournals.org Clin Cancer Res 2008;14(22) November15, 2008 7497 Cancer Research. on December 30, 2017. © 2008 American Association for clincancerres.aacrjournals.org Downloaded from define the SCF radiologically (9). In addition, the N categories used in patients with NPC are not in line with those used for other head and neck cancers, in which surgical regional lymph node levels are used to describe the location of lymph node metastases (4). The development of diagnostic and therapeutic techniques revolutionized the management of NPC and improved its 5-year relative survival rates from 50% to 75%, approximately, over the past 10 years (7, 10–12). The higher sensitivity of magnetic resonance imaging (MRI) allows more accurate evaluation of the local tumor extension and the nodal spread pattern than computerized tomography (CT), thereby improving the accuracy of the classification and changing the treatment strategies for NPC (13, 14). Furthermore, the implementation of three-dimensional conformal radiotherapy (3-DCRT) and, particularly, intensity-modulated radiation therapy (IMRT) requires the delineation of the target volume in cross-sectional imaging and the standardization of the terminology and procedures for neck irradiation. Within this framework, a common set of recommendations, known as Radiation Therapy Oncology Group (RTOG) guidelines, for delineation of neck node levels was proposed by the major international cooperative groups in Europe and in North America (9, 15). The RTOG guidelines, translating as accurately as possible the surgical guidelines into radiologic guidelines, facilitate uniform delineation of the target volumes in the neck among radiation oncologists. The present study evaluated the prognostic value of MRIdetermined variables of neck nodes in patients with NPC to determine whether MRI of the neck can provide a more predictive scheme for nodal staging in NPC than the traditional AJCC criteria. Materials andMethods Patient characteristics. Between January 2003 and December 2004, 924 patients, with newly diagnosed, biopsy-proven, and nonmetastatic NPC presented at the Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, were entered into our study. There were 685 male patients and 239 female patients, with a male to female ratio of 2.9:1, and the median age was 45 y (range, 11-78 y). Histologically, 99% (915 of 924) of the patients had WHO type II or type III disease, 0.8% (7 of 924) had WHO type I disease, and the rest 0.2% (2 of 924) had adenocarcinoma. All patients were investigated by physical examination, fiber optic examination, chest X-ray, abdominal ultrasound, and imaging studies by magnetic resonance. All patients with N2-N3 disease underwent emission computed tomography, and 6.1% (56 of 924) patients underwent positron emission tomographycomputed tomography (PET-CT). Medical records and imaging studies were analyzed retrospectively, and the patients were staged according to the 6th edition of the AJCC staging system. Retropharyngeal lymph node (RP-LN) involvement was assigned to N1 regardless of laterality (16). The distribution of stage group for the whole series was 4.9% (45 of 924) stage I, 27.1% (250 of 924) stage IIA-B, 39.2% (363 of 924) stage III, and 28.8% (266 of 924) stage IVA-B. Imaging protocol. All patients underwent MRI with a 1.5-T system (Signa CV/i, General Electric Healthcare). The area from the suprasellar cistern to the inferior margin of the sternal end of clavicle was examined with a head and neck combined coil. According to the advice of reviewer, we had provided more variables for our MR sequences and prescribed as follow: T1-weighted fast spin-echo images in the axial, coronal, and sagittal planes (repetition time of 500-600 ms and echo time of 10-20 ms, two excitations, a 22-cm field of view, and a 320 224 frequency matrix) and T2-weighted fast spin-echo MR images in the axial plane (repetition time of 4,000-6,000 ms and echo time of 95-110 ms, one excitation, a 22-cm field of view, and a 320 224 frequency matrix) were obtained before injection of contrast material. After i.v. gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) injection at a dose of 0.1 mmol/kg of body weight, spin-echo T1-weighted axial and sagittal sequences and spin-echo T1-weighted fat-suppressed coronal sequences were done sequentially, with variables similar to those used before Gd-DTPA injection. Section thickness was 5 mm with a 1-mm interslice gap for the axial plane and 6 mm with a 1-mm interslice gap for the coronal and sagittal planes. PET-CT integrates a four-slice helical CT scanner (Light Speed Plus, GE Medical System) and PET scanner (Advance Nxi, GE Medical System). The imaging and data acquisition were done on a combined PET-CT system (Discovery LS, GE Medical System). Single-photon emission computed tomography is equipped with high-resolution lowenergy collimator (Sopha DSX). Image assessment and criteria for lymph node metastasis. Two experienced radiologists separately evaluated the MR images. Any Fig. 1. MRI of patients with NPC shows nodal extracapsula